300702 天宇股份
已收盘 10-12 15:00:00
资讯
新帖
简况
天宇股份（300702）披露回购公司股份进展暨回购完成的公告，10月12日股价上涨1.53%
证券之星 · 10-12 22:53
天宇股份（300702）披露回购公司股份进展暨回购完成的公告，10月12日股价上涨1.53%
股市必读：天宇股份新发布《第六届董事会第四次会议决议公告》
证券之星 · 10-08
股市必读：天宇股份新发布《第六届董事会第四次会议决议公告》
天宇股份（300702）9月30日主力资金净卖出1250.78万元
证券之星 · 09-30
天宇股份（300702）9月30日主力资金净卖出1250.78万元
天宇股份（300702）9月28日主力资金净买入519.59万元
证券之星 · 09-28
天宇股份（300702）9月28日主力资金净买入519.59万元
天宇股份：2026年上半年CDMO业务实现营业收入1.04亿元
证券之星 · 09-28
天宇股份：2026年上半年CDMO业务实现营业收入1.04亿元
天宇股份：部分原料药产品受市场竞争加剧及价格下降影响
证券之星 · 09-28
天宇股份：部分原料药产品受市场竞争加剧及价格下降影响
9月21日天宇股份涨5.74%，湘财医药健康混合A基金重仓该股
证券之星 · 09-21
9月21日天宇股份涨5.74%，湘财医药健康混合A基金重仓该股
天宇股份(300702.SZ)子公司磷酸西格列汀原料药通过CDE评审
智通财经 · 09-04
天宇股份(300702.SZ)子公司磷酸西格列汀原料药通过CDE评审
天宇股份（300702）披露回购公司股份进展公告，9月2日股价上涨0.14%
证券之星 · 09-02
天宇股份（300702）披露回购公司股份进展公告，9月2日股价上涨0.14%
股市必读：天宇股份新发布《2026年半年度报告摘要》
证券之星 · 08-31
股市必读：天宇股份新发布《2026年半年度报告摘要》
天宇股份（300702）披露2026年半年度报告，8月28日股价下跌1.06%
证券之星 · 08-28
天宇股份（300702）披露2026年半年度报告，8月28日股价下跌1.06%
图解天宇股份中报：第二季度单季净利润同比下降7.74%
证券之星 · 08-27
图解天宇股份中报：第二季度单季净利润同比下降7.74%
天宇股份(300702)6月30日股东户数1.41万户，较上期减少5.88%
证券之星 · 08-27
天宇股份(300702)6月30日股东户数1.41万户，较上期减少5.88%
天宇股份(300702.SZ)拟出资7000万元参与设立德方鸿景股权投资基金
智通财经 · 08-05
天宇股份(300702.SZ)拟出资7000万元参与设立德方鸿景股权投资基金
天宇股份：拟认缴7000万元参与设立投资基金 出资比例49.96%
格隆汇 · 08-05
天宇股份：拟认缴7000万元参与设立投资基金 出资比例49.96%
股市必读：天宇股份新发布《关于全资子公司产品拟中选第十二批全国药品集中采购的公告》
证券之星 · 08-05
股市必读：天宇股份新发布《关于全资子公司产品拟中选第十二批全国药品集中采购的公告》
天宇股份（300702）披露回购公司股份进展公告，8月4日股价上涨7.09%
证券之星 · 08-04
天宇股份（300702）披露回购公司股份进展公告，8月4日股价上涨7.09%
天宇股份(300702.SZ)：盐酸曲唑酮片等拟中选第十二批全国药品集中采购
智通财经 · 08-04
天宇股份(300702.SZ)：盐酸曲唑酮片等拟中选第十二批全国药品集中采购
天宇股份（300702）披露提前归还闲置募集资金公告，7月28日股价上涨0.65%
证券之星 · 07-28
天宇股份（300702）披露提前归还闲置募集资金公告，7月28日股价上涨0.65%
7月17日天宇股份跌7.33%，湘财医药健康混合A基金重仓该股
证券之星 · 07-17
7月17日天宇股份跌7.33%，湘财医药健康混合A基金重仓该股
加载更多
公司概况
公司名称：
浙江天宇药业股份有限公司
所属行业：
医药制造业
上市日期：
2017-09-19
主营业务：
浙江天宇药业股份有限公司的主营业务是中间体、原料药以及制剂业务的研发、生产与销售。公司的主要产品是沙坦类抗高血压药物原料药及中间体、抗哮喘药物原料药及中间体、降血糖药物原料药及中间体、降血脂类原料药及中间体、抗凝血原料药及中间体、CDMO原料药及中间体业务。
发行价格：
22.41
{"stockData":{"symbol":"300702","market":"SZ","secType":"STK","nameCN":"天宇股份","latestPrice":22.52,"timestamp":1791788622000,"preClose":22.18,"halted":0,"volume":4607176,"delay":0,"changeRate":0.0153,"floatShares":211000000,"shares":348000000,"eps":0.2705,"marketStatus":"已收盘","change":0.34,"latestTime":"10-12 15:00:00","open":22.2,"high":23.18,"low":21.5,"amount":102000000,"amplitude":0.0757,"askPrice":22.52,"askSize":10,"bidPrice":22.51,"bidSize":103,"shortable":0,"etf":0,"ttmEps":0.2705,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791855000000},"marketStatusCode":5,"adr":0,"adjPreClose":22.18,"symbolType":"stock","openAndCloseTimeList":[[1791768600000,1791775800000],[1791781200000,1791788400000]],"highLimit":24.4,"lowLimit":19.96,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":347977159,"isCdr":false,"pbRate":2.17,"roa":"--","peRate":83.253235,"roe":"2.74%","epsLYR":0.41,"committee":0.906516,"marketValue":7836000000,"turnoverRate":0.0218,"status":0,"floatMarketCap":4755000000},"requestUrl":"/m/hq/s/300702","defaultTab":"news","newsList":[{"id":"2674805733","title":"天宇股份（300702）披露回购公司股份进展暨回购完成的公告，10月12日股价上涨1.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674805733","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674805733?lang=zh_cn&edition=full","pubTime":"2026-10-12 22:53","pubTimestamp":1791816803,"startTime":"0","endTime":"0","summary":"截至2026年10月12日收盘，天宇股份报收于22.52元，较前一交易日上涨1.53%，最新总市值为78.36亿元。公司于2026年10月12日披露《关于回购公司股份的进展暨回购完成的公告》。公告显示，浙江天宇药业股份有限公司于2026年6月10日召开董事会，审议通过回购公司股份方案，拟使用自有资金以集中竞价方式回购股份，用于员工持股计划或股权激励。截至2026年10月12日，公司累计回购股份4,001,250股，占公司总股本的1.15%，成交金额82,571,643.50元，回购方案已实施完毕。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200035835.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300702","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673439014","title":"股市必读：天宇股份新发布《第六届董事会第四次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2673439014","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673439014?lang=zh_cn&edition=full","pubTime":"2026-10-08 01:21","pubTimestamp":1791393669,"startTime":"0","endTime":"0","summary":"公司公告汇总第六届董事会第四次会议决议公告浙江天宇药业股份有限公司于2026年9月30日召开第六届董事会第四次会议，审议通过《2026年员工持股计划（草案）》及其摘要、《2026年员工持股计划管理办法》及提请股东大会授权董事会办理员工持股计划相关事项的议案，并决定召开2026年第三次临时股东大会。会议表决结果均为全票通过。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800000828.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300702","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671895279","title":"天宇股份（300702）9月30日主力资金净卖出1250.78万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671895279","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671895279?lang=zh_cn&edition=full","pubTime":"2026-09-30 15:28","pubTimestamp":1790753333,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月30日收盘，天宇股份报收于22.68元，上涨3.0%，换手率2.57%，成交量5.42万手，成交额1.23亿元。9月30日的资金流向数据方面，主力资金净流出1250.78万元，占总成交额10.2%，游资资金净流入466.82万元，占总成交额3.81%，散户资金净流入783.96万元，占总成交额6.4%。天宇股份主营业务：中间体、原料药以及制剂业务的研发、生产与销售。该股最近90天内共有2家机构给出评级，买入评级2家。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000019049.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300702"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670823542","title":"天宇股份（300702）9月28日主力资金净买入519.59万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2670823542","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670823542?lang=zh_cn&edition=full","pubTime":"2026-09-28 15:28","pubTimestamp":1790580519,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月28日收盘，天宇股份报收于22.25元，上涨4.46%，换手率1.66%，成交量3.5万手，成交额7601.23万元。9月28日的资金流向数据方面，主力资金净流入519.59万元，占总成交额6.84%，游资资金净流出131.28万元，占总成交额1.73%，散户资金净流出388.3万元，占总成交额5.11%。天宇股份主营业务：中间体、原料药以及制剂业务的研发、生产与销售。该股最近90天内共有2家机构给出评级，买入评级2家。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800014579.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300702","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670283998","title":"天宇股份：2026年上半年CDMO业务实现营业收入1.04亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2670283998","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670283998?lang=zh_cn&edition=full","pubTime":"2026-09-28 11:33","pubTimestamp":1790566387,"startTime":"0","endTime":"0","summary":"投资者提问：尊敬的董秘您好，半年报显示CDMO收入1.04亿元，同比下滑58.61%，是净利润下滑32%的首要原因。2026年上半年，公司CDMO业务实现营业收入1.04亿元，同比下降58.61%，CDMO收入下降是影响公司当期盈利水平的重要因素之一。公司未单独披露某一时点CDMO在手订单金额及同比数据。公司目前未对全年CDMO收入增速或降幅作出具体业绩指引，因此是否较上半年收窄仍需结合后续实际经营情况判断。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800010186.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300702"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670839672","title":"天宇股份：部分原料药产品受市场竞争加剧及价格下降影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2670839672","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670839672?lang=zh_cn&edition=full","pubTime":"2026-09-28 11:33","pubTimestamp":1790566384,"startTime":"0","endTime":"0","summary":"由于沙坦及非沙坦业务均包含多个产品，不同品种销售规模、价格及市场结构存在差异，因此收入与销量增速的差异不能简单理解为所有产品销售价格同比下降。报告期内，部分原料药产品确实受到市场竞争加剧及价格下降影响，对原料药业务毛利率形成了一定压力。非沙坦业务涉及多个品种，其毛利率变化受到销售品种结构、市场价格及生产成本等多重因素影响，上半年部分品种市场竞争加剧和价格下降是影响因素之一。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800010182.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300702","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669594601","title":"9月21日天宇股份涨5.74%，湘财医药健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669594601","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669594601?lang=zh_cn&edition=full","pubTime":"2026-09-21 16:46","pubTimestamp":1789980408,"startTime":"0","endTime":"0","summary":"证券之星消息，9月21日天宇股份涨5.74%，收盘报21.2元，换手率2.3%，成交量4.87万手，成交额1.02亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为湘财基金的湘财医药健康混合A。湘财医药健康混合A目前规模为0.48亿元，最新净值1.7151，较上一交易日上涨0.43%，近一年上涨0.11%。湘财医药健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100021030.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300702"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664485336","title":"天宇股份(300702.SZ)子公司磷酸西格列汀原料药通过CDE评审","url":"https://stock-news.laohu8.com/highlight/detail?id=2664485336","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664485336?lang=zh_cn&edition=full","pubTime":"2026-09-04 18:52","pubTimestamp":1788519175,"startTime":"0","endTime":"0","summary":"智通财经APP讯，天宇股份(300702.SZ)发布公告，公司全资子公司浙江京圣药业有限公司磷酸西格列汀原料药于近日通过国家药品监督管理局药品审评中心(简称“CDE”)审评。磷酸西格列汀是一种降糖药，能够帮助控制血糖水平，主要用于治疗2型糖尿病。磷酸西格列汀原料药现已通过CDE审评，尚须取得浙江省药品监督管理局GMP符合性检查结果为“符合要求”的公示后，方可在国内上市销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492208.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["GDXJ","CDE","LU1223082196.USD","BK4017","SGDM","XME","LU1223083913.SGD","SIL","LU1223082519.USD","300702","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664981016","title":"天宇股份（300702）披露回购公司股份进展公告，9月2日股价上涨0.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664981016","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664981016?lang=zh_cn&edition=full","pubTime":"2026-09-02 22:56","pubTimestamp":1788360973,"startTime":"0","endTime":"0","summary":"截至2026年9月2日收盘，天宇股份报收于21.77元，较前一交易日上涨0.14%，最新总市值为75.75亿元。该股当日开盘22.0元，最高22.04元，最低21.48元，成交额达3702.3万元，换手率为0.81%。近日，天宇股份发布《关于回购公司股份进展的公告》。公告显示，公司于2026年6月10日召开第六届董事会第二次会议，审议通过回购公司股份方案，拟使用自有资金以集中竞价交易方式回购股份，用于员工持股计划或股权激励。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200043360.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300702","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663040156","title":"股市必读：天宇股份新发布《2026年半年度报告摘要》","url":"https://stock-news.laohu8.com/highlight/detail?id=2663040156","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663040156?lang=zh_cn&edition=full","pubTime":"2026-08-31 07:06","pubTimestamp":1788131175,"startTime":"0","endTime":"0","summary":"关于2026年半年度计提资产减值准备的公告浙江天宇药业股份有限公司于2026年8月27日召开第六届董事会第三次会议，审议通过《关于2026年半年度计提资产减值准备的议案》。本次增加后，公司及子公司2026年度向银行申请综合授信额度合计不超过人民币48亿元。浙江天宇药业股份有限公司2026年半年度非经营性资金占用及其他关联资金往来情况汇总表浙江天宇药业股份有限公司发布了2026年半年度非经营性资金占用及其他关联资金往来情况汇总表。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100001764.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300702"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662306221","title":"天宇股份（300702）披露2026年半年度报告，8月28日股价下跌1.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662306221","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662306221?lang=zh_cn&edition=full","pubTime":"2026-08-28 19:13","pubTimestamp":1787915629,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，天宇股份报收于21.37元，较前一交易日下跌1.06%，最新总市值为74.36亿元。该股当日开盘21.6元，最高21.61元，最低21.05元，成交额达5867.8万元，换手率为1.3%。公司于近日披露《2026年半年度报告》。公告显示，本报告期营业收入为2,010,725,291.69元，较上年同期调整后增长13.23%；归属于上市公司股东的净利润为103,908,571.56元，同比下降32.12%；归属于上市公司股东的扣除非经常性损益的净利润为101,829,588.23元，同比下降27.93%；经营活动产生的现金流量净额为415,609,720.51元，同比增长4,734.66%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800044649.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300702","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662701839","title":"图解天宇股份中报：第二季度单季净利润同比下降7.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662701839","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662701839?lang=zh_cn&edition=full","pubTime":"2026-08-27 19:11","pubTimestamp":1787829111,"startTime":"0","endTime":"0","summary":"证券之星消息，天宇股份2026年中报显示，上半年度公司主营收入20.11亿元，同比上升13.23%；归母净利润1.04亿元，同比下降32.12%；扣非净利润1.02亿元，同比下降27.93%；其中2026年第二季度，公司单季度主营收入11.99亿元，同比上升17.97%；单季度归母净利润6171.71万元，同比下降7.74%；单季度扣非净利润6023.38万元，同比上升2.16%；负债率47.65%，投资收益170.1万元，财务费用4206.95万元，毛利率30.14%。财报数据概要请见下图:本文数据来源于天宇股份2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700045323.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300702"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662705853","title":"天宇股份(300702)6月30日股东户数1.41万户，较上期减少5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662705853","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662705853?lang=zh_cn&edition=full","pubTime":"2026-08-27 18:15","pubTimestamp":1787825717,"startTime":"0","endTime":"0","summary":"证券之星消息，近日天宇股份披露，截至2026年6月30日公司股东户数为1.41万户，较3月31日减少879.0户，减幅为5.88%。在化学制药行业个股中，天宇股份股东户数低于行业平均水平，截至6月30日，化学制药行业平均股东户数为3.67万户。从股价来看，2026年3月31日至2026年6月30日，天宇股份区间跌幅为13.55%，在此期间股东户数减少879.0户，减幅为5.88%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700043764.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300702","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657446005","title":"天宇股份(300702.SZ)拟出资7000万元参与设立德方鸿景股权投资基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2657446005","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657446005?lang=zh_cn&edition=full","pubTime":"2026-08-05 20:12","pubTimestamp":1785931923,"startTime":"0","endTime":"0","summary":"智通财经APP讯，天宇股份 发布公告，公司与上海德鸿私募基金管理中心、临海市靖越金融投资集团有限公司、临海市瀚海投资有限公司在浙江省台州市临海市签署了《合伙协议》，共同投资设立浙江德方鸿景股权投资合伙企业。该基金总认缴出资额为1.40亿元，其中公司作为有限合伙人以自有资金认缴出资7000万元，出资比例为49.96%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1476458.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300702","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657546919","title":"天宇股份：拟认缴7000万元参与设立投资基金 出资比例49.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657546919","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657546919?lang=zh_cn&edition=full","pubTime":"2026-08-05 19:11","pubTimestamp":1785928264,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["300702","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657656965","title":"股市必读：天宇股份新发布《关于全资子公司产品拟中选第十二批全国药品集中采购的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657656965","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657656965?lang=zh_cn&edition=full","pubTime":"2026-08-05 02:43","pubTimestamp":1785868990,"startTime":"0","endTime":"0","summary":"全资子公司诺得药业盐酸曲唑酮片、甲苯磺酸艾多沙班片拟中选第十二批全国药品集中采购。公司公告汇总关于全资子公司产品拟中选第十二批全国药品集中采购的公告浙江天宇药业股份有限公司全资子公司浙江诺得药业有限公司参与第十二批全国药品集中采购，产品盐酸曲唑酮片和甲苯磺酸艾多沙班片拟中选；采购周期自中选结果执行之日起至2029年12月31日；相关采购协议签订及后续事项存在不确定性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500002287.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300702","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656522505","title":"天宇股份（300702）披露回购公司股份进展公告，8月4日股价上涨7.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656522505","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656522505?lang=zh_cn&edition=full","pubTime":"2026-08-04 22:38","pubTimestamp":1785854297,"startTime":"0","endTime":"0","summary":"截至2026年8月4日收盘，天宇股份报收于21.61元，较前一交易日上涨7.09%，最新总市值为75.2亿元。该股当日开盘20.33元，最高21.75元，最低20.33元，成交额达1.34亿元，换手率为2.98%。公司于2026年8月4日披露《关于回购公司股份进展的公告》。公告显示，浙江天宇药业股份有限公司于2026年6月10日召开第六届董事会第二次会议，审议通过《关于回购公司股份方案的议案》，拟使用自有资金以集中竞价交易方式回购公司股份，用于员工持股计划或股权激励计划。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400041681.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300702","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656364145","title":"天宇股份(300702.SZ)：盐酸曲唑酮片等拟中选第十二批全国药品集中采购","url":"https://stock-news.laohu8.com/highlight/detail?id=2656364145","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656364145?lang=zh_cn&edition=full","pubTime":"2026-08-04 16:43","pubTimestamp":1785833019,"startTime":"0","endTime":"0","summary":"智通财经APP讯，天宇股份(300702.SZ)发布公告，公司全资子公司浙江诺得药业有限公司参加了国家组织药品联合采购办公室(简称“联采办”)组织的第十二批全国药品集中采购的投标工作，根据联采办于2026年7月31日在上海阳光医药采购网发布的《第12批国家组织药品集中带量采购拟中选结果公示》显示，公司产品盐酸曲唑酮片和甲苯磺酸艾多沙班片拟中选本次集中采购。拟中选产品的采购周期自中选结果执行之日起至2029年12月31日。若后续采购合同顺利签订并实施，预计将进一步提升该产品销量和市场占有率，增强公司品牌影响力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475763.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300702","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654008522","title":"天宇股份（300702）披露提前归还闲置募集资金公告，7月28日股价上涨0.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2654008522","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654008522?lang=zh_cn&edition=full","pubTime":"2026-07-28 17:46","pubTimestamp":1785231973,"startTime":"0","endTime":"0","summary":"截至2026年7月28日收盘，天宇股份报收于20.08元，较前一交易日上涨0.65%，最新总市值为69.87亿元。该股当日开盘19.87元，最高20.39元，最低19.82元，成交额达4002.34万元，换手率为0.95%。近日，天宇股份发布《关于提前归还暂时补充流动资金的闲置募集资金的公告》。公司实际使用7,000.00万元，已于2026年7月2日提前归还4,000.00万元，剩余3,000.00万元于2026年7月28日全部归还至募集资金专用账户，使用期限未超过12个月，并已通知保荐机构及保荐代表人。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072800028946.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300702","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652060994","title":"7月17日天宇股份跌7.33%，湘财医药健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2652060994","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652060994?lang=zh_cn&edition=full","pubTime":"2026-07-17 16:55","pubTimestamp":1784278525,"startTime":"0","endTime":"0","summary":"证券之星消息，7月17日天宇股份跌7.33%，收盘报20.23元，换手率2.5%，成交量5.27万手，成交额1.1亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为湘财基金的湘财医药健康混合A。湘财医药健康混合A目前规模为0.4亿元，最新净值1.7379，较上一交易日上涨0.77%，近一年上涨13.78%。湘财医药健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700030700.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300702","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1791838109140,"stockEarnings":[{"period":"1week","weight":-0.0071},{"period":"1month","weight":0.1083},{"period":"3month","weight":0.0744},{"period":"6month","weight":-0.0238},{"period":"1year","weight":-0.1249},{"period":"ytd","weight":-0.0433}],"compareEarnings":[{"period":"1week","weight":-0.0117},{"period":"1month","weight":-0.0234},{"period":"3month","weight":-0.0428},{"period":"6month","weight":-0.0571},{"period":"1year","weight":-0.0256},{"period":"ytd","weight":-0.0432}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江天宇药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"14076人(较上一季度减少5.88%)","perCapita":"15000股","listingDate":"2017-09-19","address":"浙江省台州市黄岩区黄岩江口化工开发区","registeredCapital":"34797万元","survey":" 浙江天宇药业股份有限公司的主营业务是中间体、原料药以及制剂业务的研发、生产与销售。公司的主要产品是沙坦类抗高血压药物原料药及中间体、抗哮喘药物原料药及中间体、降血糖药物原料药及中间体、降血脂类原料药及中间体、抗凝血原料药及中间体、CDMO原料药及中间体业务。","listedPrice":22.41},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"天宇股份(300702)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供天宇股份(300702)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"天宇股份,300702,天宇股份股票,天宇股份股票老虎,天宇股份股票老虎国际,天宇股份行情,天宇股份股票行情,天宇股份股价,天宇股份股市,天宇股份股票价格,天宇股份股票交易,天宇股份股票购买,天宇股份股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"天宇股份(300702)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供天宇股份(300702)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}